Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05) - Concepedia

Concepedia

Publication | Open Access

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

DOI Full Paper Access

93

Citations

13

References

2023

Year

Ernest Nadal, Delvys Rodríguez‐Abreu, Marta Simó, Bartomeu Massutí, Óscar Juan, G. Huidobro, Rafael López Castro, Javier de Castro, Anna Estival, Joaquín Mosquera,

Journal of Clinical Oncology

Abstract

Atezolizumab plus carboplatin and pemetrexed demonstrates activity in patients with advanced nonsquamous NSCLC with untreated brain metastases with an acceptable safety profile.

References

	Year	Citations

Page 1